NCT04658147 2025-12-18Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Active not recruiting31 enrolled